Literature DB >> 16966744

Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.

J Michael Paterson1, Andreas Laupacis, Ken Bassett, Geoffrey M Anderson.   

Abstract

Prescription drug plan managers seek "real-world" evidence regarding the safety and effectiveness of drugs and drug coverage policies. University-based pharmacoepidemiologists with access to administrative health data can help meet these information needs and, by collaborating with other health plans, exploit variations in plan policy. Canada, with its universal health insurance, public drug benefit plans, and population-based linked health care databases, is an ideal setting for such research. Here we describe our initial experience in collaborating with researchers and drug plan managers in British Columbia and Ontario.

Entities:  

Mesh:

Year:  2006        PMID: 16966744     DOI: 10.1377/hlthaff.25.5.1436

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  1 in total

1.  A secure distributed logistic regression protocol for the detection of rare adverse drug events.

Authors:  Khaled El Emam; Saeed Samet; Luk Arbuckle; Robyn Tamblyn; Craig Earle; Murat Kantarcioglu
Journal:  J Am Med Inform Assoc       Date:  2012-08-07       Impact factor: 4.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.